Criatec 2

What is Criatec 2?

Criatec 2 is a venture capital fund managed by Buzano Investimentos, focusing on seed, early stage, and later stage investments within the Investment Management industry. Established in 2013 and operating from Sao Paulo, Brazil, Criatec 2 keenly invests in innovative companies across several sectors such as health tech, nanotechnology, Fintech, Information Technology, logistics, Smart Cities, agronomy, and others.

Portfolio companies include Confiance Medical, a leader in minimally invasive surgery technology; Nanox, a nanotechnology firm creating antimicrobial solutions; Datarisk, offering predictive modeling for financial institutions; DotLegend, specializing in Consumer Experience; among others.

Criatec 2 engages in nurturing its investees like Auvo, OnCase, and PinMyPet, providing not just funding but strategic and operational support. This can be seen in its comprehensive investment strategy that includes selection of companies with high growth potential and aligning them with the fund's expertise and network of operational advisors and regional managers.

Criatec 2's approach is not just to fund but to create meaningful partnerships that drive innovation and growth within the Brazilian startup ecosystem.

Their commitment to actively manage and support investments until divestment shows a hands-on approach, committing to startups in sectors poised for growth leveraging technology, healthcare advancements, sustainable practices in agronomy, and improving productivity through digital solutions in various industries.